Shopping Cart
- Remove All
Your shopping cart is currently empty
OTUB1/USP8-IN-1 HCL is a potent dual inhibitor of OTUB1 and USP8 with potential antitumour activity, inhibiting both OTUB1 and USP8. OTUB1/USP8-IN-1 may be used in the study of leukaemia.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $162 | Backorder | |
| 5 mg | $357 | Backorder | |
| 10 mg | $429 | Backorder | |
| 25 mg | $987 | Backorder | |
| 50 mg | $1,520 | Backorder | |
| 100 mg | $1,980 | Backorder |
| Description | OTUB1/USP8-IN-1 HCL is a potent dual inhibitor of OTUB1 and USP8 with potential antitumour activity, inhibiting both OTUB1 and USP8. OTUB1/USP8-IN-1 may be used in the study of leukaemia. |
| Targets&IC50 | OTUB1:0.17 nM, USP8:0.28 nM |
| In vitro | OTUB1/USP8-IN-1 (compound 61) exhibits antiproliferative effects in KRAS-WT (H1975, EBC-1, H1703) and KRAS-mutated (H23, A549) NSCLC cell lines when treated with concentrations ranging from 10 nM to 10 μM for 72 hours[1]. Additionally, treatment with OTUB1/USP8-IN-1 at 500 nM for 24 hours leads to a decrease in protein levels of both UBE2N and EGFR in H1975 cells[1]. |
| In vivo | In the H1975 xenograft mouse model, treatment with OTUB1/USP8-IN-1 (compound 61) at concentrations ranging from 10 nM to 10 μM for 72 hours results in a decrease in tumor burden[1]. |
| Synonyms | OTUB1/USP8-IN-1 HCl(2858800-98-1 Free base) |
| Molecular Weight | 463.29 |
| Formula | C22H17Cl2FN2O4 |
| Smiles | O=C1C2=C(C(C3=CC=CC=C31)=O)OC(C4=C(C(O[C@H]5CN(CC5)C)=CC=C4F)Cl)=N2.Cl |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.